comparemela.com

Latest Breaking News On - Icmr latest study - Page 1 : comparemela.com

ICMR study: A 2 lineage of Monkeypox mutating, more genomic surveillance needed

The Indian Council of Medical Research (ICMR) in its recent study said that genome sequences from India covering 90-99 per cent genome were found to be belonging to A.2 Lineage of clade IIb.

Covid19 Health Updates: From proning to tips for diabetes, hypertension patients, things to keep in mind

URL copied Representative image With surging COVID 19 cases, it has become of utmost importance to keep yourself indoors and safe. Patients with existing conditions like diabetes and hypertension should be more careful and must keep in mind certain things to order to have a healthy life. As per the health experts, the coronavirus attacks the lungs in the most harmful ways. Also, amid reports of shortage of oxygen in the hospitals during the second wave of Covid across the country, it is important to take measures to build one s immunity. From busting myths to latest updates related to COVID 19, check out this space: 

COVID 19 latest update: Coronavirus vaccine Covaxin works against multiple variants of SARS-COV-2, claims ICMR

India reports 3.14 lakh new Covid cases, highest-ever daily spike India reported 3,14,835 Covid-19 new cases in the last 24 hours, the highest single-day spike since the onset of the pandemic early last year, taking the overall infection tally to 1,59,30,965 on Thursday, according to data from the Union Health Ministry.   Apr 22, 2021 10:27 AM (IST) Posted by Vaishali Jain Dr Harsh Vardhan, Minister of Health and Family shared the results of the trails on Twitter stating that Covaxin found efficacious against multiple variants of SARS-COV-2, neutralising even the double mutant strain. Apr 22, 2021 10:23 AM (IST) Posted by Vaishali Jain Covaxin demonstrates overall interim clinical efficacy of 78%

Covaxin neutralises double mutant strain of Covid-19: ICMR

URL copied Covaxin neutralises double mutant strain of Covid-19: ICMR Indigenously developed COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday. Bharat Biotech s Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe with another 60 in the process. ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the ICMR tweeted. ICMR-National Institute of Virology has successfully isolated and cultured multiple variants of concern of SARS-CoV-2 virus: B.1.1.7 (the UK variant), B.1.1.28 (Brazil variant ) and B.1.351 (South Africa variant).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.